AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2009

Nov 30, 2009

34915_dirs_2009-11-30_589cb546-1c8f-4e5c-afdc-0da471a0532f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-11-23

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-23	Common Stock	S	10000	$0.93	Disposed	33687000	Direct
2009-11-24	Common Stock	S	30045	$0.84	Disposed	33656955	Direct
2009-11-25	Common Stock	S	34000	$0.89	Disposed	33622955	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour?s Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.